Covid-19 man­u­fac­tur­ing roundup: Brazil to man­u­fac­ture Vaxzevria at home; As­traZeneca ramp up in Spain gets the OK

Thanks to a tech­nol­o­gy trans­fer to a promi­nent Latin Amer­i­can sci­ence in­sti­tu­tion, Brazil is now able to man­u­fac­ture the As­traZeneca Covid-19 vac­cine do­mes­ti­cal­ly.

Fiocruz, a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER